Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2025

Month: January

Request Number: A-2021-001973

Request Summary: The Screening acceptance letter(s) sent from Health Canada to any and all generic drug manufacturer(s) for any and all Abbreviated New Drug Submission(s) (ANDS) for the medicinal ingredient risperidone which appear(s) on the list of Generic Drug Submissions under Review (GSUR).The Module 2.2 indicating the brand name of the reference drug product and the dosage form of risperidone in any and all ANDS for the medicinal ingredient risperidone which appear(s) on the list of GSUR.

Disposition: Disclosed in part

Number of pages: 2

Date modified: